Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeremy Godefroy

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|February 10, 2021
[<sup>18</sup>F]FDG -PET/CT uptake reveals a single metastasis inside vertebral hemangioma - Catch me if you scanYogev Cohen, Albert Grinshpun, Karen Meir, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 6, 2021
Correction to: [<sup>18</sup>F]FDG -PET/CT uptake reveals a single metastasis inside vertebral hemangioma, catch me if you scanYogev Cohen, Albert Grinshpun, Karen Meir, et al.
Harefuah|January 25, 2022
[THE MAGIC OF IMMUNOTHERAPY - ANTI-PD1 TREATMENT IN ADENOCARCINOMA OF THE GASTROESOPHAGEAL JUNCTION]Noa Daskal, Albert Grinspun, Jeremy Godefroy, et al.
JCEM Case Reports|November 1, 2023
<sup>99m</sup>Tc MIBI Scintigraphy for Classification of Amiodarone-induced ThyrotoxicosisDror Itzkovich, Simona Ben-Haim, Jeremy Godefroy, et al.
Frontiers in Pediatrics|October 24, 2022
Case report: Robust response of metastatic clear cell sarcoma treated with cabozantinib and immunotherapyRakefet Sidlik Muskatel, Nir Pillar, Jeremy Godefroy, et al.
Physical Biology|October 15, 2005
Toward an artificial cell based on gene expression in vesiclesVincent Noireaux, Roy Bar-Ziv, Jeremy Godefroy, et al.
Clinical Nuclear Medicine|May 21, 2020
Posttreatment FDG-Avid Splenic Lesions in DLBCL and HD: Clinical and Radiographic Characteristics for Risk AssessmentBoaz Nachmias, Jeremy Godefroy, Eyal Rozenbach, et al.
EJNMMI Research|May 29, 2024
Distribution and predictors of F-18-FDG uptake values of non-malignant cervical lymph nodes in pediatric patientsJeremy Godefroy, Raphael Godefroy, Koral Vedder, et al.
EJNMMI Physics|June 20, 2018
Reducing the number of CTs performed to monitor personalized dosimetry during peptide receptor radionuclide therapy (PRRT)Alexandre Chicheportiche, Faozi Artoul, Arnon Schwartz, et al.
EJNMMI Physics|January 25, 2020
Dosimetry after peptide receptor radionuclide therapy: impact of reduced number of post-treatment studies on absorbed dose calculation and on patient managementAlexandre Chicheportiche, Simona Ben-Haim, Simona Grozinsky-Glasberg, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
European Journal of Nuclear Medicine and Molecular Imaging|February 10, 2021
[<sup>18</sup>F]FDG -PET/CT uptake reveals a single metastasis inside vertebral hemangioma - Catch me if you scanYogev Cohen, Albert Grinshpun, Karen Meir, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 6, 2021
Correction to: [<sup>18</sup>F]FDG -PET/CT uptake reveals a single metastasis inside vertebral hemangioma, catch me if you scanYogev Cohen, Albert Grinshpun, Karen Meir, et al.
Harefuah|January 25, 2022
[THE MAGIC OF IMMUNOTHERAPY - ANTI-PD1 TREATMENT IN ADENOCARCINOMA OF THE GASTROESOPHAGEAL JUNCTION]Noa Daskal, Albert Grinspun, Jeremy Godefroy, et al.
JCEM Case Reports|November 1, 2023
<sup>99m</sup>Tc MIBI Scintigraphy for Classification of Amiodarone-induced ThyrotoxicosisDror Itzkovich, Simona Ben-Haim, Jeremy Godefroy, et al.
Frontiers in Pediatrics|October 24, 2022
Case report: Robust response of metastatic clear cell sarcoma treated with cabozantinib and immunotherapyRakefet Sidlik Muskatel, Nir Pillar, Jeremy Godefroy, et al.
Physical Biology|October 15, 2005
Toward an artificial cell based on gene expression in vesiclesVincent Noireaux, Roy Bar-Ziv, Jeremy Godefroy, et al.
Clinical Nuclear Medicine|May 21, 2020
Posttreatment FDG-Avid Splenic Lesions in DLBCL and HD: Clinical and Radiographic Characteristics for Risk AssessmentBoaz Nachmias, Jeremy Godefroy, Eyal Rozenbach, et al.
EJNMMI Research|May 29, 2024
Distribution and predictors of F-18-FDG uptake values of non-malignant cervical lymph nodes in pediatric patientsJeremy Godefroy, Raphael Godefroy, Koral Vedder, et al.
EJNMMI Physics|June 20, 2018
Reducing the number of CTs performed to monitor personalized dosimetry during peptide receptor radionuclide therapy (PRRT)Alexandre Chicheportiche, Faozi Artoul, Arnon Schwartz, et al.
EJNMMI Physics|January 25, 2020
Dosimetry after peptide receptor radionuclide therapy: impact of reduced number of post-treatment studies on absorbed dose calculation and on patient managementAlexandre Chicheportiche, Simona Ben-Haim, Simona Grozinsky-Glasberg, et al.
Pageof 2